Jefferies Financial Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-120,651
Closed -$467K 1930
2024
Q3
$467K Hold
120,651
﹤0.01% 1004
2024
Q2
$280K Hold
120,651
﹤0.01% 1132
2024
Q1
$340K Hold
120,651
﹤0.01% 1173
2023
Q4
$384K Hold
120,651
﹤0.01% 1311
2023
Q3
$398K Hold
120,651
﹤0.01% 1146
2023
Q2
$398K Hold
120,651
﹤0.01% 1251
2023
Q1
$399K Hold
120,651
﹤0.01% 1153
2022
Q4
$436K Buy
+120,651
New +$789K ﹤0.01% 1105

Jefferies Financial Group's LUMO Position: Q4 2024 in Review

Jefferies Financial Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 120,651 shares — an estimated $467K sold.

Jefferies Financial Group first reported a position in LUMO in Q4 2022 and held it in 8 quarters. The position peaked at $467K in Q3 2024. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

  • Jefferies Financial Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 120,651 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $467K.
  • Jefferies Financial Group first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2022 and held it in 8 quarters.
  • Jefferies Financial Group's Lumos Pharma, Inc. Common Stock position peaked at $467K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Jefferies Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.